Jay A. Fishman Ltd’s First Trust NYSE Arca Biotechnology Index Fund FBT Stock Holding History

Jay A. Fishman Ltd’s Portfolio FBT Stock Details FBT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q3	–	Sell	-2,250	Closed	-$257K	–	95
2017 Q2	$257K	Sell	2,250 -2,550	-53%	-$274K	0.05%	82
2017 Q1	$505K	Sell	4,800 -125	-3%	-$12.5K	0.11%	64
2016 Q4	$448K	Sell	4,925 -3,200	-39%	-$300K	0.11%	70
2016 Q3	$810K	Sell	8,125 -2,000	-20%	-$196K	0.2%	53
2016 Q2	$906K	Sell	10,125 -2,100	-17%	-$193K	0.23%	54
2016 Q1	$1.07M	Buy	12,225 +2,450	+25%	+$216K	0.28%	49
2015 Q4	$1.1M	Sell	9,775 -400	-4%	-$43.1K	0.27%	49
2015 Q3	$1.03M	Buy	10,175 +925	+10%	+$110K	0.25%	52
2015 Q2	$1.15M	Buy	9,250 +1,100	+13%	+$133K	0.24%	53
2015 Q1	$964K	Buy	+8,150	New	+$921K	0.2%	59

Other funds holding FBT

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

RJA

Raymond James & Associates St Petersburg, Florida $164B AUM 33.91% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return

JPCCM

J&P (China) Capital Management Hong Kong, China $586M AUM 82.64% 1-Year Est. Return

HFM

Hartford Financial Management Hartford, Connecticut $448M AUM 32.11% 1-Year Est. Return

Jay A. Fishman Ltd's FBT Position: Q3 2017 in Review

Jay A. Fishman Ltd sold out of First Trust NYSE Arca Biotechnology Index Fund (FBT) in Q3 2017, closing a stake of 2,250 shares — an estimated $257K sold.

Jay A. Fishman Ltd first reported a position in FBT in Q1 2015 and held it in 10 quarters. The position peaked at $1.15M in Q2 2015. 116 funds tracked by Wall St. Rank hold FBT as of Q3 2017.

Jay A. Fishman Ltd reported no remaining First Trust NYSE Arca Biotechnology Index Fund position as of Q3 2017 after selling out during the quarter.
Jay A. Fishman Ltd sold 2,250 First Trust NYSE Arca Biotechnology Index Fund shares in Q3 2017, an estimated $257K.
Jay A. Fishman Ltd first reported a position in First Trust NYSE Arca Biotechnology Index Fund in Q1 2015 and held it in 10 quarters.
Jay A. Fishman Ltd's First Trust NYSE Arca Biotechnology Index Fund position peaked at $1.15M in Q2 2015.
116 funds tracked by Wall St. Rank held First Trust NYSE Arca Biotechnology Index Fund as of Q3 2017.

Based on Jay A. Fishman Ltd's 13F filing for Q3 2017, filed 31 Oct 2017.